Bicara Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCAX and other ETFs, options, and stocks.About BCAX
Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor.
BCAX Key Statistics
Stock Snapshot
With a market cap of 1.17B, Bicara Therapeutics(BCAX) trades at $18.50. The stock has a price-to-earnings ratio of -8.32.
As of 2026-03-05, Bicara Therapeutics(BCAX) stock has fluctuated between $17.71 and $18.92. The current price stands at $18.50, placing the stock +4.5% above today's low and -2.2% off the high.
Bicara Therapeutics(BCAX) shares are trading with a volume of 945.9K, against a daily average of 727.78K.
In the last year, Bicara Therapeutics(BCAX) shares hit a 52-week high of $19.71 and a 52-week low of $7.80.
In the last year, Bicara Therapeutics(BCAX) shares hit a 52-week high of $19.71 and a 52-week low of $7.80.
Analyst ratings
77%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.